What’s New

News

May 10, 2024

Alimentiv: A Global GI-Focused CRO with end-to-end clinical trial services and imaging solutions leading with innovation at DDW 2024

London, Ontario, Canada, May 13, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce two lecture presentations and six poster presentations at the Digestive Disease Week (DDW) Meeting…

Article

Mar 19, 2024

Countdown to Discovery: Previewing the Upcoming GI Clinical Trial Conferences In 2024

Explore GI clinical trial conferences in 2024 with our curated roster of events. This chronological listing offers an overview of the most influential gatherings worldwide, providing unparalleled oppo…

Publication

Oct 4, 2022

CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease

Brian Feagan, Christopher Ma, Claire E Parker, Geert D’Haens, Niels Vande Casteele, Stefanie C McFarlane, Vipul Jairath.

News

Sep 15, 2022

AcelaBio (US) Inc. obtains accreditation from the College of American Pathologists (CAP)

San Diego, CA, USA, Release: September 15, 2022 – AcelaBio (US) Inc., a contract research organization delivering histopathology and precision medicine laboratory services for global clinical trials…

Video

Sep 13, 2022

Discovery Accelerated: Clinical Trials in Pediatric IBD

News

Aug 17, 2022

Alimentiv Health Trust announces the appointment of New Board Members to the Alimentiv Holdings Board of Directors 

London, ON, CANADA, Release: August 18, 2022 Alimentiv Health Trust is pleased to announce the appointment of Dr. Amara Siva, Mr. John Fox and Mr. Paul Rothwell to the Alimentiv Holdings Board of…

Publication

Jul 16, 2022

Heterogeneity in Efficacy and Safety Endpoints for Pediatric Clinical Trials in Inflammatory Bowel Disease: A Need for Harmonization

Eileen Crowley, Vipul Jairath.

News

Jul 14, 2022

Employee Spotlight – Jill Klein

At Alimentiv, our employees come first. We engage inspired and talented individuals who are motivated by our mission and vision, and we continue to learn more about our employees and their unique and …